/ /
Substance use disorder treatment providers, clinicians, outreach workers, and public health agencies should be aware of the following information.
The Center for Forensic Science Research & Education (CFSRE) released an adulterant alert about diphenhydramine (Benadryl), with recommendations for...
FDA warns consumers Apetamin is potentially dangerous and has not been reviewed for safety and effectiveness
DEA has issued the attached Public Safety Alert regarding xylazine.
The Center for Forensic Science Research & Education (CFSRE) released a toxic adulterant alert this week regarding phenylbutazone. In...
/ /
The U.S. Drug Enforcement Administration is alerting the public of a sharp nationwide increase in the lethality of fentanyl-laced...
The United States Food and Drug Administration (FDA) is communicating to health care professionals about serious risks associated with...
The Drug Enforcement Administration is advising the public of an alarming emerging trend of colorful fentanyl available across the...
This Alert is being sent out to make Law Enforcement and our partners aware of this trend and to...
The Pharmaceutical Cargo Security Coalition (PCSC) offers supply chain security intelligence; access to contacts from industry, government and vendor...
National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913
Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy
